Paper8093319
Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine.
Bertilsson L and 7 others. Lancet, 1993. Cited by 201 papers, by iCite.
Cite this record
ConductScience Library. Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine. Papers, record 8093319. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8093319
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Debrisoquin | Major topic |
| Metabolic Diseases | Major topic |
| Neurotic Disorders | Major topic |
| Female | |
| Humans | |
| Hydroxylation | |
| Polymorphism, Restriction Fragment Length |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 8095589 | Debrisoquine polymorphism: mechanism for very rapid oxidative phenotype. | https://conductscience.org/library/papers/8095589 |
Source PubMed
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 201 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37669183 | PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting. | Clin Pharmacol Ther | 2023 | https://conductscience.org/library/papers/37669183 | PubMed |
| 33363564 | How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing? | Front Genet | 2020 | https://conductscience.org/library/papers/33363564 | PubMed |
| 30173302 | Completed suicides of citalopram users-the role of CYP genotypes and adverse drug interactions. | Int J Legal Med | 2019 | https://conductscience.org/library/papers/30173302 | PubMed |
| 27997040 | Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. | Clin Pharmacol Ther | 2017 | https://conductscience.org/library/papers/27997040 | PubMed |
| 27520753 | The Role of Metabolites of Antidepressants in the Treatment of Depression. | CNS Drugs | 1997 | https://conductscience.org/library/papers/27520753 | PubMed |
| 25110110 | Human gene copy number variation and infectious disease. | Hum Genet | 2014 | https://conductscience.org/library/papers/25110110 | PubMed |
| 24913012 | Addressing phenoconversion: the Achilles' heel of personalized medicine. | Br J Clin Pharmacol | 2015 | https://conductscience.org/library/papers/24913012 | PubMed |
| 24278778 | Nature and nurture of human pain. | Scientifica (Cairo) | 2013 | https://conductscience.org/library/papers/24278778 | PubMed |
| 24240528 | Genetics of adverse reactions to haloperidol in a mouse diallel: a drug-placebo experiment and Bayesian causal analysis. | Genetics | 2014 | https://conductscience.org/library/papers/24240528 | PubMed |
| 23226058 | Role of cytochrome P450 genotype in the steps toward personalized drug therapy. | Pharmgenomics Pers Med | 2011 | https://conductscience.org/library/papers/23226058 | PubMed |
| 22899355 | Toxicogenetics--cytochrome P450 microarray analysis in forensic cases focusing on morphine/codeine and diazepam. | Int J Legal Med | 2013 | https://conductscience.org/library/papers/22899355 | PubMed |
| 22183189 | The risk of recurrence in breast cancer patients treated with tamoxifen: polymorphisms of CYP2D6 and ABCB1. | AAPS J | 2012 | https://conductscience.org/library/papers/22183189 | PubMed |
| 21432264 | Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer. | Environ Health Prev Med | 2002 | https://conductscience.org/library/papers/21432264 | PubMed |
| 20525348 | Copy number variation and cytidine analogue cytotoxicity: a genome-wide association approach. | BMC Genomics | 2010 | https://conductscience.org/library/papers/20525348 | PubMed |
| 20405111 | Fluconazole-induced intoxication with phenytoin in a patient with ultra-high activity of CYP2C9. | Eur J Clin Pharmacol | 2010 | https://conductscience.org/library/papers/20405111 | PubMed |
| 19902987 | Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. | Clin Pharmacokinet | 2009 | https://conductscience.org/library/papers/19902987 | PubMed |
| 19817501 | Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. | Clin Pharmacokinet | 2009 | https://conductscience.org/library/papers/19817501 | PubMed |
| 17535043 | Conventional and atypical antipsychotics in the elderly : a review. | Clin Drug Investig | 2003 | https://conductscience.org/library/papers/17535043 | PubMed |
| 16783493 | The impact of the CYP2D6-polymorphism on dose recommendations for current antidepressants. | Eur Arch Psychiatry Clin Neurosci | 2006 | https://conductscience.org/library/papers/16783493 | PubMed |
| 16771600 | The AmpliChip CYP450 genotyping test: Integrating a new clinical tool. | Mol Diagn Ther | 2006 | https://conductscience.org/library/papers/16771600 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8093319
GET https://conductscience.org/api/papers/v1/8093319/cited_by?page=2